 SEATTLE, Nov. 4, 2020 PRNewswire -- CTI BioPharma Corp. Nasdaq: CTIC today announced an oral presentation supporting the Companys pacritinib development program in graft versus host disease GVHD at the 62nd American Society of Hematology ASH Annual Meeting Exposition, being... 